Abstract
A squalene-based adjuvant system with modifications in its formulation was created. Two variants of an adjuvant formulation were proposed. It was shown that the use of the proposed system helps to enhance immunogenicity of an antigen in a subunit vaccine based on RBD of spike protein (S) of SARS-CoV-2 by 4-fold compared to the use of a classical aluminum hydroxide-based adjuvant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
